--- title: 'Associate Director, Data & Information Architecture at REGENXBIO' canonical: 'https://feeny.ai/job/associate-director-data-information-architecture-regenxbio-rockville-b0m5vrmrm33p' type: 'job' last_seen: '2026-09-14' --- # Associate Director, Data & Information Architecture at REGENXBIO - **Company:** REGENXBIO - **Location:** Rockville, MD - **Employment:** full-time - **Work type:** hybrid - **Posted:** 2026-07-20 - **Last confirmed live:** 2026-09-14 - **Apply:** https://jobs.lever.co/regenxbio/6ddb8ec0-99ff-439a-aac4-35c7d14124da ## Job description ## Who we are REGENXBIO is an exceptional place to work. You'll have the opportunity to collaborate with some of the best and the brightest people, touch amazing science, and be a part of extraordinary plans. Our core values: Trust, Accountability, Perseverance, and Innovation drive everything we do. We aim to bring these values to life every day with all that we do, and we believe that what we do matters - to patients, to their families, and to their communities. The opportunity: As Associate Director, Data & Information Architecture, you’ll be responsible for designing and executing the enterprise data architecture strategy that enables REGENXBIO’s commercial growth. Working closely with business & IT leadership, you’ll build and lead a secure, scalable commercial data warehouse; integrate internal and third-party data; establish master and reference data standards; and partner across Commercial, Medical, Legal, and IT to deliver trusted analytics with clear lineage, quality, and privacy controls. This is a “build and scale” role focused on enabling growth: ensuring systems and data support the next phase of the business. What you'll be doing: - Oversee data pipelines and system-to-system data flows ensuring reliable and scalable infrastructure. - Help define and maintain the target commercial data architecture for sales, CRM, payer, patient-support, and claims-linked analytics. - Own the ERP (Oracle Cloud) data model and become an expert on ERP Business Process functions including but not limited to Procurement, Planning, Inventory, Supply Chain, and Manufacturing; be able to extract and integrated data from those functions. - Identify the company’s internal and external data sources, lead the design and operation of a data warehouse and its landing, harmonized, conformed, and semantic layers. - Serve as design authority for commercial-data initiatives and chair architectural review, model review, and commercial-data governance forums. - Translate commercial priorities into quarterly roadmaps, objectives and key results, release plans, and measurable business outcomes. - Collaborate with others on the team and with Business stakeholders in gathering requirements, designing systems, and demonstrating and reviewing databases. Establish scalable processes for system governance, data integrity, and ongoing optimization - Document designs and database architecture, adhere to Change Management and Validation processes, use source code control repositories (ie; Git), conduct code reviews, eventually implement continuous integration and design with constant attention on security and keeping applications safe from penetrable threats. - Determine the requirements for new databases occasionally create and publish reports. - Audit database regularly to maintain quality - It is imperative that REGENXBIO employees embody our core values by working collaboratively, building strong relationships, and using clear communication to meet shared objectives. What we're looking for: We set our employees up for success.  To be successful in this role and help us achieve our goals, we are looking for someone with the following skills and qualifications: - Bachelor of Science in Computer Science, CIS, Mathematics, Life Science or equivalent required. - Minimum of 12 years of database architecture/engineering or Enterprise Data experience ideally in Oracle, SQL Server or equivalent. - Deep experience designing and operating enterprise data warehouses and dimensional models for analytics. - Strong command of SQL, data modeling, ELT/ETL design, orchestration, metadata, and business intelligence semantic modeling. - Hands-on experience integrating multiple commercial-data domains, including some combination of CRM/sales, marketing, payer, patient-support, specialty pharmacy, and claims data. - Strong understanding of the operation of an ERP system. - Exposure to or participation in Agile/Scrum and traditional waterfall SDLC experience. - Outstanding interpersonal skills, a can-do and team player attitude, excellent, clear written and verbal communication skills, and keen attention to detail. - Ability to work effectively in a high demand, fast-paced, and evolving environment, work on multiple projects at a time. - Must be willing to be onsite in our Rockville office on a semi-regular basis Why should you apply? By joining REGENXBIO, you will have the opportunity to be a part of a growing company and incredible team passionate about developing novel AAV gene therapy products to our patients. In addition, professional development is important to us.  By joining our team, you’ll have the opportunity to be exposed to challenging projects and development resources to help you grow personally and professionally. We are proud to offer a comprehensive rewards package which includes a market-competitive base salary, an annual performance-based bonus program, stock grants at all levels, and benefits such as health, dental, and vision insurance, retirement plan with 401(k) match, summer hours, and more! The estimated compensation range for this role is $186,000 to $251,000 annually. The actual salary offered to the final candidate depends on a number of factors such as relevant work experience, skills, education, and years of experience. ## About REGENXBIO ## Company Overview - **One-liner**: REGENXBIO is a clinical-stage biotechnology company developing one-time gene therapies for rare and retinal diseases using its proprietary AAV vector platform. - **Entity Type**: Public (NASDAQ: RGNX) - **Headquarters**: Rockville, Maryland, United States - **Founded**: 2008 (founded as a company; operations began in 2009) - **Founders**: Not publicly listed as individual founders; the company was spun out from the gene therapy research of the University of Pennsylvania and licensed its NAV Technology Platform from the university. ## Core Business - **Primary industry**: Biotechnology – Gene Therapy (AAV-based) - **Target customers**: B2B (pharma partners like AbbVie, Nippon Shinyaku) and B2G (regulatory agencies, clinical trial sites); ultimate customers are patients with rare and retinal diseases (Duchenne muscular dystrophy, MPS I, MPS II, wet AMD, diabetic retinopathy). - **Mission or purpose statement**: “To improve lives through the curative potential of gene therapy.” [regenxbio.com](https://www.regenxbio.com/culture-careers/) ## Products & Services - **NAV® Technology Platform**: Proprietary AAV vector gene delivery platform (including AAV8 and AAV9) used for internal programs and licensed to partners (e.g., Novartis for ZOLGENSMA®). - **ABBV-RGX-314** (in collaboration with AbbVie): Investigational one-time gene therapy for wet age-related macular degeneration (wet AMD) and diabetic retinopathy (DR). In pivotal clinical trials. - **RGX-202** (Duchenne muscular dystrophy): Phase I/II/III AFFINITY DUCHENNE® trial; pivotal phase expected to support BLA submission in 2026 using accelerated approval pathway. [ir.regenxbio.com](https://ir.regenxbio.com/static-files/92731f97-50e3-4285-b793-d2cdc99611aa) - **RGX-121** (MPS II – Hunter syndrome): In partnership with Nippon Shinyaku; late-stage development. - **RGX-111** (MPS I – Hurler syndrome): In partnership with Nippon Shinyaku; clinical development. - **Manufacturing**: In-house cGMP production facility (REGENXBIO Manufacturing Innovation Center – RMIC) in Rockville, MD, operational since mid-2022. ## Market Standing - **Valuation/Market Cap**: $447.8 million (as of recent data). [linkedin.com](https://linkedin.com/company/regenx) - **Key Metric**: Annual Revenue $170.4 million (primarily from license and collaboration revenue). [linkedin.com](https://linkedin.com/company/regenx) - **Notable Investors/Partners**: - AbbVie (collaboration for ABBV-RGX-314) - Nippon Shinyaku (partnerships for RGX-121 and RGX-111) - Novartis (licensee for ZOLGENSMA® using NAV vectors) - **Growth Signals**: - Headcount: 296 employees (+1.3% YoY). [linkedin.com](https://linkedin.com/company/regenx) - BLA submission for RGX-202 targeted for 2026. - RMIC facility operational since 2022, enabling scalable clinical and commercial manufacturing. - Scholarly output: 160 works, 7,337 citations, field-weighted citation impact of 2.6 (highly influential). [linkedin.com](https://linkedin.com/company/regenx) ## Competitive Advantages - **Proprietary NAV Technology Platform**: Exclusive rights to a large portfolio of AAV vectors (including AAV8 and AAV9), the foundation for multiple approved and investigational gene therapies. [ir.regenxbio.com](https://ir.regenxbio.com/static-files/92731f97-50e3-4285-b793-d2cdc99611aa) - **End-to-end capabilities**: Integrated in-house R&D, preclinical development, clinical development, and cGMP manufacturing. - **Proven platform**: Thousands of patients have been treated with AAV vectors from the NAV platform (including via Novartis’ ZOLGENSMA®). - **Late-stage pipeline**: Multiple programs in pivotal or near-pivotal trials (RGX-202, ABBV-RGX-314) with clear regulatory pathways. ## Strategic Focus - **Near-term**: Advance RGX-202 toward BLA submission in 2026; continue pivotal trials for ABBV-RGX-314 in wet AMD and diabetic retinopathy. - **Long-term**: Expand pipeline in retinal, neuromuscular, and neurodegenerative diseases; leverage RMIC for commercial-scale manufacturing; deepen partnerships with AbbVie and Nippon Shinyaku. - **Platform expansion**: Ongoing research to expand NAV vector capabilities and develop new AAV-based therapies. ## Why Work Here - **Mission-driven culture**: “Patient-focused, driven by results, fosters collaboration.” Core values emphasize accountability, innovation, and serving patients with limited therapeutic options. [regenxbio.com](https://www.regenxbio.com/culture-careers/) - **Impactful work**: Opportunity to work on one-time gene therapies that could fundamentally alter the course of devastating diseases. - **Growth & stability**: Public company with late-stage pipeline, strong partnerships, and a clear path to commercialization. - **Location & facilities**: Headquarters in Rockville, MD, with a state-of-the-art cGMP manufacturing facility (RMIC) on site. - **Work policy**: Not explicitly stated as remote/hybrid; positions appear to be on-site (based on job listings in Rockville and field-based Medical Science Liaison roles). - **Perks**: Comprehensive and competitive benefits for employees and families. [regenxbio.com](https://www.regenxbio.com/culture-careers/) - **Engineering & science culture**: High scholarly output and citation impact; emphasis on cross-functional collaboration between research, manufacturing, and clinical teams. - **Recruitment note**: REGENXBIO warns of fraudulent job offers; all applications go through their official Lever portal. [regenxbio.com](https://www.regenxbio.com/culture-careers/) ## Sources 1. [regenxbio.com – Culture & Careers](https://www.regenxbio.com/culture-careers/) 2. [linkedin.com – REGENXBIO company page](https://linkedin.com/company/regenx) 3. [ir.regenxbio.com – 10-K Filing (Business Overview)](https://ir.regenxbio.com/static-files/92731f97-50e3-4285-b793-d2cdc99611aa) 4. [ir.regenxbio.com – Investor Overview](https://ir.regenxbio.com/investor-overview) 5. [jobs.lever.co – REGENXBIO careers](https://jobs.lever.co/regenxbio) ## Other roles at REGENXBIO - [Associate Director, People Business Partner](https://feeny.ai/job/associate-director-people-business-partner-regenxbio-rockville-fmx3gbzx681y) — Rockville, MD - [Director, Commercial Data, Advanced Analytics & Forecasting](https://feeny.ai/job/director-commercial-data-advanced-analytics-forecasting-regenxbio-remote-88y6fvc5kv5j) - [Market Development Director - Southeast Region](https://feeny.ai/job/market-development-director-southeast-region-regenxbio-remote-b1hhp987p5v1) - [Associate Director, Rare Disease Product Marketing](https://feeny.ai/job/associate-director-rare-disease-product-marketing-regenxbio-rockville-r2p05phcvmx8) — Rockville, MD - [Senior Medical Science Liaison - DMD/Neuromuscular (South)](https://feeny.ai/job/senior-medical-science-liaison-dmd-neuromuscular-south-regenxbio-remote-4qggqdykm9ym) - [Senior Medical Science Liaison - DMD/Neuromuscular (Northeast)](https://feeny.ai/job/senior-medical-science-liaison-dmd-neuromuscular-northeast-regenxbio-remote-47qpcgnnyhpc) - [Senior Medical Science Liaison - DMD/Neuromuscular (West Coast)](https://feeny.ai/job/senior-medical-science-liaison-dmd-neuromuscular-west-coast-regenxbio-west-coast-yerem2kwy7ca) — West Coast - [Senior Director, Global Program Development Lead - DMD/Neuromuscular](https://feeny.ai/job/senior-director-global-program-development-lead-dmd-neuromuscular-regenxbio-xbereeg0zrc8) — Rockville, MD - [Senior Director/Director, Medical Science Liaisons (Neuromuscular/DMD)](https://feeny.ai/job/senior-director-director-medical-science-liaisons-neuromuscular-dmd-regenxbio-aeca83gb75e2)